Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dipeptidyl peptidase 3 sets the threshold for immune activation and survival during experimental bacterial infection.

Nature communications·2026
Same author

Dissecting first-episode psychosis heterogeneity with clustering analyses: a systematic review.

Neuroscience and biobehavioral reviews·2026
Same author

Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice.

EMBO molecular medicine·2026
Same author

Withdrawal Note: Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.

EMBO molecular medicine·2026
Same author

Generation of two LGMDR4 patients derived induced pluripotent stem cell line carrying the SGCB frameshift mutation (p.Gly129_Arg130insGlnTer).

Stem cell research·2026
Same author

Brain-heart interactions in late-onset major depressive disorder revealed by multimodal HRV-driven fMRI.

Communications biology·2026

Related Experiment Video

Updated: Jun 20, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Cell based therapy for Duchenne muscular dystrophy.

Andrea Farini1, Paola Razini, Silvia Erratico

  • 1Stem Cell Laboratory, Department of Neurological Science, Centro Dino Ferrari, University of Milan, Fondazione IRCCS Policlinico Mangiagalli Regina Elena, Italy.

Journal of Cellular Physiology
|August 19, 2009
PubMed
Summary
This summary is machine-generated.

Stem cell therapy offers a promising approach for Duchenne muscular dystrophy (DMD). Identifying effective myogenic stem cells is key to advancing DMD treatments, potentially through combined gene and cell therapies.

More Related Videos

Molecular Imaging to Target Transplanted Muscle Progenitor Cells
09:24

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Published on: March 27, 2013

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Related Experiment Videos

Last Updated: Jun 20, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Molecular Imaging to Target Transplanted Muscle Progenitor Cells
09:24

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Published on: March 27, 2013

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Area of Science:

  • Biomedical Science
  • Regenerative Medicine
  • Genetics

Background:

  • Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder caused by mutations in the dystrophin gene.
  • Stem cell therapy presents an attractive treatment strategy for DMD due to the potential for significant therapeutic effects from a small cell number.

Purpose of the Study:

  • To review and discuss various types of myogenic stem cells for potential use in treating DMD.
  • To highlight the critical need for identifying stem cell populations that can efficiently regenerate muscle tissue for DMD therapy.

Main Methods:

  • Literature review and discussion of existing research on myogenic stem cells.
  • Exploration of different stem cell types and their regenerative capabilities relevant to DMD.

Main Results:

  • Multiple types of myogenic stem cells show potential for DMD treatment.
  • Efficient muscle regeneration is a critical factor for successful stem cell therapy in DMD.

Conclusions:

  • The optimal stem cell population for effective muscle regeneration in DMD remains a key area for identification.
  • A combination of gene therapy and stem cell therapy is speculated to be the most promising future direction for DMD treatment.